PANCR-AS1 is robustly expressed across both IBD and non-IBD cohorts (TPM > 1 in 41/140 samples, median 0.42 TPM), while PANCR had more sporadic expression (TPM > 1 in 29/140 samples, median 0.17 TPM) and was filtered out prior to differential expression analysis. The gene discussed is PANCR; the disease is inflammatory bowel disease.